Advertisement
YOU ARE HERE: LAT HomeCollectionsEprex Drug
IN THE NEWS

Eprex Drug

FEATURED ARTICLES
BUSINESS
June 28, 2002 | Reuters
Johnson & Johnson said that the number of patients who have developed a rare blood disorder when treated with the firm's anemia drug has risen to 124 worldwide and that one of those patients died. In a letter to Canadian doctors, Johnson & Johnson said it is investigating possible triggers of the blood disorder, called pure red-blood cell aplasia. Aplasia is a condition in which the bone marrow fails to produce vital red blood cells--the opposite of the drug's intended function.
ARTICLES BY DATE
BUSINESS
June 28, 2002 | Reuters
Johnson & Johnson said that the number of patients who have developed a rare blood disorder when treated with the firm's anemia drug has risen to 124 worldwide and that one of those patients died. In a letter to Canadian doctors, Johnson & Johnson said it is investigating possible triggers of the blood disorder, called pure red-blood cell aplasia. Aplasia is a condition in which the bone marrow fails to produce vital red blood cells--the opposite of the drug's intended function.
Los Angeles Times Articles
|